Skip to main content
. 2006;5(8):689–702. doi: 10.1038/nrd2030

Table 3.

PDE inhibition and selectivity

Drug Geometric mean IC50 values (μM) [fold selectivity versus PDE5 in parentheses]
PDE1 PDE2 PDE3 PDE4 PDE5 PDE6 (rod) PDE6 (cone) PDE7A PDE8A PDE9A PDE10A PDE11A
Sildenafil 0.281 [80] >30 [>8,570] 16.2 [4,630] 7.68 [2,190] 0.00350 0.037 [11] 0.034 [10] 21.3 [6,090] 29.8 [8,510] 2.61 [750] 9.80 [2,800] 2.73 [780]
Tadalafil >30 [>4,450] >100 [>14,800] >100 [>14,800] >100 [>14,800] 0.00674 1.26 [187] 1.30 [193] >100 [>14,800] >100 [>14,800] >100 [>14,800] >100 [>14,800] 0.037 [5]
Vardenafil 0.070 [500] 6.20 [44,290] >1.0 [>7,140] 6.10 [43,570] 0.00014 0.0035 [25] 0.0006 [4] >30 [>214,000] >30 [>214,000] 0.581 [4,150] 3.0 [21,200] 0.162 [1,160]
IC50 values were determined using either native enzyme purified from human tissue (PDE1, heart; PDEs 2, 3 and 5, corpus cavernosum; PDE4, skeletal muscle; PDE6, retina) or using recombinant human enzymes expressed in Sf9 cells (PDEs 7?11) and purified by anion-exchange chromatography. Adapted from Ref. 29. IC50, drug concentration necessary to inhibit 50% of enzyme activity; PDE, phosphodiesterase.
HHS Vulnerability Disclosure